Oculis Holding AG (OCS) EBITDA (2022 - 2026)

Oculis Holding AG's EBITDA history runs 5 years deep, the most recent figure standing at -$27.7 million for Q1 2026.

• In Q1 2026, EBITDA fell 24.89% year-over-year to -$27.7 million; the TTM figure through Mar 2026 stood at -$78.7 million (down 17.77% YoY), while the FY2025 annual figure was -$98.5 million, down 18.38% from the prior year.
• EBITDA for Q1 2026 stood at -$27.7 million, down from -$25.8 million in the prior quarter.
• The five-year high for EBITDA was -$20926.9 in Q3 2024, with the low at -$48.5 million in Q1 2023.
• The 5-year median for EBITDA is -$16.1 million (2024), against an average of -$17.5 million.
• Peak annual rise in EBITDA reached 99.86% in 2024, while the deepest fall reached 108.06% in 2024.
• Oculis Holding AG's EBITDA stood at -$11.5 million in 2022, then retreated by 19.07% to -$13.7 million in 2023, then tumbled by 43.44% to -$19.7 million in 2024, then sank by 31.02% to -$25.8 million in 2025, then slipped by 7.48% to -$27.7 million in 2026.
• Business Quant data shows OCS's EBITDA at -$27.7 million in Q1 2026, -$25.8 million in Q4 2025, and -$25372.2 in Q3 2025.